A Look At Establishment Labs Holdings (ESTA) Valuation After Updated Revenue Guidance And Motiva US Growth Outlook

Simply Wall St.

Jan 22

AdvertisementWhy Establishment Labs Holdings (ESTA) just grabbed investors’ attention Establishment Labs Holdings (ESTA) updated the market with preliminary, unaudited revenue guidance for the fourth ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2605584804"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2605584804\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2605584804?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","is_english":true,"pubTime":"2026-01-22 05:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2605584804","market":"sg","top_or_hot":-1,"title":"A Look At Establishment Labs Holdings (ESTA) Valuation After Updated Revenue Guidance And Motiva US Growth Outlook","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementWhy Establishment Labs Holdings (ESTA) just grabbed investors’ attention Establishment Labs Holdings (ESTA) updated the market with preliminary, unaudited revenue guidance for the fourth ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-esta/establishment-labs-holdings/news/a-look-at-establishment-labs-holdings-esta-valuation-after-u\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At Establishment Labs Holdings (ESTA) Valuation After Updated Revenue Guidance And Motiva US Growth Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At Establishment Labs Holdings (ESTA) Valuation After Updated Revenue Guidance And Motiva US Growth Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-22 05:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-esta/establishment-labs-holdings/news/a-look-at-establishment-labs-holdings-esta-valuation-after-u><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementWhy Establishment Labs Holdings (ESTA) just grabbed investors’ attention Establishment Labs Holdings (ESTA) updated the market with preliminary, unaudited revenue guidance for the fourth ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-esta/establishment-labs-holdings/news/a-look-at-establishment-labs-holdings-esta-valuation-after-u\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ESTA","symbol_name":"Establishment Labs Holdings Inc.","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-esta/establishment-labs-holdings/news/a-look-at-establishment-labs-holdings-esta-valuation-after-u","article_id":"2605584804","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-esta/establishment-labs-holdings/news/a-look-at-establishment-labs-holdings-esta-valuation-after-u","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2605584804","pubTimestamp":1769030417,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Why Establishment Labs Holdings (ESTA) just grabbed investors’ attention\nEstablishment Labs Holdings (ESTA) updated the market with preliminary, unaudited revenue guidance for the fourth quarter and full year 2025, highlighting expected contributions from Motiva implant sales in the United States.\nSee our latest analysis for Establishment Labs Holdings.\nAt a share price of $64.63, Establishment Labs has recently seen a 13.15% 1 month share price decline. However, its 90 day share price return...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"ESTA":"Establishment Labs Holdings Inc."},"translate_title":"更新收入指引和Motiva美国增长前景后的Establishment Labs Holdings(ESTA)估值一览","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ESTA":1.5},"content_text":"AdvertisementWhy Establishment Labs Holdings (ESTA) just grabbed investors’ attention Establishment Labs Holdings (ESTA) updated the market with preliminary, unaudited revenue guidance for the fourth quarter and full year 2025, highlighting expected contributions from Motiva implant sales in the United States. See our latest analysis for Establishment Labs Holdings. At a share price of $64.63, Establishment Labs has recently seen a 13.15% 1 month share price decline. However, its 90 day share price return of 29.65% and 1 year total shareholder return of 81.75% suggest underlying momentum that investors are still weighing against earlier years of weaker total shareholder returns. If news like this has you reassessing your healthcare exposure, it could be a good moment to look beyond a single name and review healthcare stocks as potential additions to your watchlist. With the shares pulling back despite strong recent gains and new revenue guidance on the table, the real question now is whether Establishment Labs is still undervalued or if the market is already pricing in future growth. Price-to-Sales of 9.8x: Is it justified? On a P/S of 9.8x, Establishment Labs is priced well above both its own estimated fair P/S of 5.4x and the US Medical Equipment peer average of 3.4x. The P/S ratio compares the company’s market value with its revenue, which is useful here because Establishment Labs is still loss making and earnings based metrics such as P/E are not yet meaningful. A higher P/S usually signals that investors are paying more for each dollar of current sales, often where they see strong potential in future revenue growth. For Establishment Labs, that premium sits alongside forecasts that revenue could grow faster than 20% a year and that earnings are expected to improve from current losses. The gap between the current 9.8x P/S and the 5.4x level suggested as a fair ratio is wide. There is a clear difference between where the market is pricing the stock today and where a regression based fair multiple suggests it could settle over time. The contrast with the Medical Equipment industry average P/S of 3.4x is even starker, as Establishment Labs trades at close to three times that level, which points to expectations that are far more optimistic than those embedded in the broader sector. Explore the SWS fair ratio for Establishment Labs Holdings Result: Price-to-Sales of 9.8x (OVERVALUED) However, you still have to weigh risks such as ongoing net losses of US$82.98m and the possibility that high expectations baked into a 9.8x P/S will compress. Find out about the key risks to this Establishment Labs Holdings narrative. Another View: DCF points to a smaller gap While the 9.8x P/S ratio paints Establishment Labs as expensive, our DCF model suggests something closer to fair. With the shares at US$64.63 versus an estimated fair value of US$60.61, the gap is modest rather than extreme. This raises a simple question: is the market only slightly ahead of itself, or just pricing in growth a bit early? Look into how the SWS DCF model arrives at its fair value. ESTA Discounted Cash Flow as at Jan 2026Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Establishment Labs Holdings for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 877 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.  Build Your Own Establishment Labs Holdings Narrative If you see the numbers differently, or simply prefer to test your own assumptions against the data, you can build a personalized view in minutes with Do it your way. A great starting point for your Establishment Labs Holdings research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision. Looking for more investment ideas? If you stop at a single stock, you risk missing other clear opportunities, so use the Simply Wall St Screener to keep your watchlist working harder for you.  Spot potential value by checking out these 877 undervalued stocks based on cash flows that stand out on cash flow based metrics before the crowd pays attention. Tap into powerful themes in artificial intelligence with these 23 AI penny stocks that tie real businesses to this fast moving technology trend. Scan for income focused ideas using these 13 dividend stocks with yields > 3% that may offer yields above 3% alongside listed financial metrics.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Establishment Labs Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}